Ophthalmology News and Research

RSS

Ophthalmology is the specialized field of medicine that focuses on the health of the eye. It includes the anatomy, physiology and diseases that may affect the eye. Historically, the science of ophthalmology encompassed all aspects of visual function, both in health and in illness. Additionally, ophthalmology also includes animal eyes as ocular function and optic diseases are similar among humans and animals.

VisionCare Ophthalmic Technologies to present on its implantable telescope technology

VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for individuals with age-related macular degeneration (AMD), today announced upcoming scientific and corporate presentations on its implantable telescope technology.

21 Oct 2009

Lux Biosciences to present on LX211 at 2009 AAO annual conference

Lux Biosciences, Inc., a privately held biotechnology company focused on the development and commercialization of therapies for serious ophthalmic diseases, today announced that the company’s experimental drug LX211 (LUVENIQ; oral voclosporin) will be featured in several presentations at the 2009 American Academy of Ophthalmology annual conference and American Uveitis Society meeting being held October 24-26 in San Francisco.

21 Oct 2009

New dual-port ophthalmic green laser photocoagulator introduced by IRIDEX

IRIDEX Corporation today announced the introduction of the IQ 532(TM) dual-port ophthalmic green laser photocoagulator which will be featured at the 2009 American Academy of Ophthalmology meeting in San Francisco.

21 Oct 2009

IRIDEX announces launch of a Modular Multi-Wavelength laser photocoagulator solution

IRIDEX Corporation today announced the introduction of a Modular Multi-Wavelength laser photocoagulator solution, which will be featured at the 2009 American Academy of Ophthalmology meeting in San Francisco.

21 Oct 2009

University Children's Eye Center to use SRS hybrid EMR for pediatric ophthalmology practice

SRS, the leader in high-performance hybrid EMR solutions, today announced that University Children's Eye Center has selected the SRS high-performance hybrid EMR for its high-volume pediatric ophthalmology practice located in East Brunswick, New Jersey.

21 Oct 2009

Human neural stem cells protect cone photoreceptors: StemCells preclinical data

StemCells, Inc. announced today new preclinical data showing that its human neural stem cells protect cone photoreceptors (cones) in the eye from progressive degeneration and preserve visual function long term.

20 Oct 2009

Lux Biosciences raises $50 million through Series B venture financing

Lux Biosciences, Inc., a privately held biotechnology company focused on the development and commercialization of therapies for serious ophthalmic diseases, today announced that the company has closed a $50 million Series B venture financing. Participants in the funding were current investors in Lux Biosciences, HBM Bioventures, Novo A/S, Prospect Venture Partners and SV Life Sciences (SVLS), as well as SVLS' publicly traded fund, International Biotechnology Trust plc.

19 Oct 2009

JMCR and Cases Journal return to BioMed Central's publishing portfolio

BioMed Central is once again publishing the Journal of Medical Case Reports (JMCR) and Cases Journals. Since their inception, both these journals, which currently provide over 2000 freely accessible case reports have received widespread recognition and high quality submissions from across the medical community.

15 Oct 2009

Vision scientists identify an intricate process that allows the human eye to adapt quickly to darkness

Ever wonder how your eyes adjust during a blackout? When we go from light to near total darkness, cells in the retina must quickly adjust. Vision scientists at Washington University School of Medicine in St. Louis have identified an intricate process that allows the human eye to adapt to darkness very quickly. The same process also allows the eye to function in bright light.

14 Oct 2009

Harvard researchers unite in fight against antibiotic resistance

The National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) have awarded $5 million to an interdisciplinary group of Harvard researchers to launch the "Harvard-wide Program on Antibiotic Resistance."

14 Oct 2009

Bioluminescence imaging distinguishes tumor growth in vivo; leads to early treatment of eye cancer

At the moment, doctors rely on biopsy analysis to determine the progression of eye cancer. However, researchers now believe that a new technology, bioluminescence imaging (BLI), will allow doctors to detect tumors earlier and quickly choose a method of treatment that doesn't necessarily involve eye surgery.

14 Oct 2009

Clinical trial results of the LensAR Laser System to be presented at the 2009 AAO and PAAO joint meeting

LensAR, Inc., a leading developer of next generation laser technology for cataract surgery and other ocular applications, today announced that data from a recently completed clinical trial of the LensAR Laser System will be presented at the upcoming 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and Pan-American Academy of Ophthalmology (PAAO). The meeting will be held October 23 - 27, 2009 in San Francisco, CA.

13 Oct 2009

Increasing number of pre-term infants experience eye disorders

As more extremely pre-term infants survive in Sweden, an increasing number of babies are experiencing vision problems caused by abnormalities involving the retina, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

13 Oct 2009

Report shows that visual impairments are associated with the risk of death in older adults

Visual problems that cannot be corrected are associated with increased risk of death among individuals between the ages of 49 and 74, and all visual impairments may be associated with the risk of death in older adults, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

13 Oct 2009

Controlled trial comparing Bevacizumab to Ranibizumab finds no difference in efficacy

Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).

9 Oct 2009

Lpath reports positive Phase 1 clinical trial results of iSONEP in wet-AMD patients

Lpath, Inc., the category leader in lipidomics-based therapeutics, reported positive summary results of its single-dose Phase 1 clinical trial of iSONEP™ in wet-AMD patients.

8 Oct 2009

Omeros announces the pricing of its initial public offering of 6.82 million shares

Omeros Corporation today announced the pricing of its initial public offering of 6.82 million shares of its common stock at a price of $10.00 per share. The underwriters have the option to purchase up to an additional 1.02 million shares to cover over-allotments, if any.

8 Oct 2009

NEI awards Case Western Reserve $1.57M for bacterial keratitis research

Researchers at Case Western Reserve University School of Medicine have been awarded a $1.57 million renewal grant from the National Eye Institute (NEI) of the National Institutes of Health to continue their study of corneal infections, specifically, bacterial keratitis, associated with contact lens wear. The grant will extend the work initiated last year with the receipt of a $2.4 million, five-year grant from the NEI.

8 Oct 2009

Roche and Genentech obtain license to use SurModics’ drug delivery system

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it has signed a License and Development Agreement with Roche and Genentech, Inc., a wholly-owned member of the Roche Group.

7 Oct 2009

IP Advocate collaborates with Marion Kauffman Foundation on education and policy initiatives

Sharing a mutual goal of helping researchers turn their discoveries into products that help people and stimulate the economy, IP Advocate (http://www.IPAdvocate.org) founder and noted scientist Dr. Renee Kaswan is collaborating with the Ewing Marion Kauffman Foundation (http://www.kauffman.org) on a range of education and policy initiatives.

7 Oct 2009

Ophthalmology News and Research

Further Reading

VisionCare Ophthalmic Technologies to present on its implantable telescope technology

Lux Biosciences to present on LX211 at 2009 AAO annual conference

New dual-port ophthalmic green laser photocoagulator introduced by IRIDEX

IRIDEX announces launch of a Modular Multi-Wavelength laser photocoagulator solution

University Children's Eye Center to use SRS hybrid EMR for pediatric ophthalmology practice

Human neural stem cells protect cone photoreceptors: StemCells preclinical data

Lux Biosciences raises $50 million through Series B venture financing

JMCR and Cases Journal return to BioMed Central's publishing portfolio

Vision scientists identify an intricate process that allows the human eye to adapt quickly to darkness

Harvard researchers unite in fight against antibiotic resistance

Bioluminescence imaging distinguishes tumor growth in vivo; leads to early treatment of eye cancer

Clinical trial results of the LensAR Laser System to be presented at the 2009 AAO and PAAO joint meeting

Increasing number of pre-term infants experience eye disorders

Report shows that visual impairments are associated with the risk of death in older adults

Controlled trial comparing Bevacizumab to Ranibizumab finds no difference in efficacy

Lpath reports positive Phase 1 clinical trial results of iSONEP in wet-AMD patients

Omeros announces the pricing of its initial public offering of 6.82 million shares

NEI awards Case Western Reserve $1.57M for bacterial keratitis research

Roche and Genentech obtain license to use SurModics’ drug delivery system

IP Advocate collaborates with Marion Kauffman Foundation on education and policy initiatives

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News